Skip to Content

Health Care

Congressman Valadao joins McCarthy, Schweikert to Introduce Bill to Combat Valley Fever

| Posted in Press Releases

Congressman David G. Valadao (CA-22) joined Congressman David Schweikert (AZ-01) and Speaker Emeritus Kevin McCarthy (CA-20) to introduce the Finding Orphan-disease Remedies with Antifungal Research and Development (FORWARD) Act. This legislation supports various research and development programs with the goal of developing new drugs, treatments, and vaccines to combat Valley Fever

Congressman Valadao Introduces Resolution to Raise Awareness on Rare Brain Disease

| Posted in Press Releases
Valadao Press Release Banner

Congressman David G. Valadao (CA-22) introduced a bipartisan resolution to designate November 12, 2023, as Creutzfeldt-Jakob Disease Awareness Day. Creutzfeldt-Jakob Disease (CJD) is a rare brain disease that causes a rapid decline in a person’s cognitive health, and often leads to death within only a few months to one year following the onset of symptoms. Longtime Bakersfield Mayor Harvey L. Hall passed away from CJD in 2018.

Congressman Valadao Participates in Valley Fever Task Force Roundtable

| Posted in Press Releases
Rep. Valadao joins the Valley Fever Task Force Roundtable

Congressman David G. Valadao (CA-22) joined Speaker Kevin McCarthy (CA-20), Congressman David Schweikert (AZ-01), and other members of the Congressional Valley Fever Task Force to host a roundtable discussion regarding Valley Fever treatments and ongoing vaccine developments. The roundtable included medical experts, researchers, and patient advocates to discuss the impacts of Valley Fever across the Western United States.

Congressman Valadao Co-Leads Bipartisan Bill to Address Physician Shortage

| Posted in Press Releases
Valadao Press Release Banner

Congressman David G. Valadao (CA-22) joined Congressman Brad Schneider (IL-10) to introduce the Conrad State 30 and Physician Access Reauthorization Act of 2023. The legislation reauthorizes and modifies the Conrad 30 Program, which allows foreign doctors studying in the United States to obtain a visa following medical residency if they practice in a medically-underserved area for at least three years.